🔍 Safety of a JAKi Across 15,000 Patient-Years of Data Now in the RheumNow poster hall: Safety outcomes with a JAKi from 11 Phase 3 trials in adult patients with RA, PsA, AS, and nr-axSpA. Sponsored by AbbVie US Medical Affairs. https://t.co/yeif38wKIY https://t.co/earZnqZLSI

• Safety of a JAKi Across 15,000 Patient-Years of Data | RheumNow